Positron-emission tomography imaging of early events after transplantation of islets of langerhans

Transplantation

Volumn 79, Issue 3, 2005, Pages 353-355

  Toso, Christian ^a   Zaidi, Habib ^a   Morel, Philippe ^a   Armanet, Mathieu ^a   Andres, Axel ^a   Pernin, Nadine ^a   Baertschiger, Reto ^a   Slosman, Daniel ^a   Bühler, Leo H ^a   Bosco, Domenico ^a   Berney, Thierry ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Fluorodeoxyglucose; Islet transplantation; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG HALF LIFE; EARLY DIAGNOSIS; ENDOCRINE CELL; GLUCOSE BLOOD LEVEL; INCUBATION TIME; INSULIN DEPENDENCE; MALE; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN BLOOD FLOW; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RISK ASSESSMENT;

ANIMALS; FLUORODEOXYGLUCOSE F18; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 20044366536     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000149501.50870.9D     Document Type: Article

References (12)

1. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
2. Shapiro J, Ryan E, McGhee-Wilson D, et al. Prospective comparison of clinical outcomes with fresh vs cultured islets at a single institution. American Transplant Congress, Boston, 2004.
3. Ritz-Laser B, Oberholzer J, Toso C, et al. Molecular detection of circulating beta-cells after islet transplantation. Diabetes 2002; 51: 557.
4. Shapiro AM, Hao EG, Lakey JR, et al. Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 2001; 71: 1709.
5. Paty BW, Bonner-Weir S, Laughlin MR, et al. Toward development of imaging modalities for islets after transplantation: insights from the national institute of health workshop on beta cell imaging. Transplantation 2004; 77: 1133.
6. Sweet IR, Cook DL, Lernmark A, et al. Systematic screening of potential Beta-cell imaging agents. Biochem Biophys Res Commun 2004; 314: 976.
7. Triponez F, Oberholzer J, Morel P, et al. Xenogeneic islet re-transplantation in mice triggers an accelerated, species-specific rejection. Immunology 2000; 101: 548.
8. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992; 19:
9. Melder RJ, Elmaleh D, Brownell AL, et al. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Methods 1994; 175: 79.
10. Adonai N, Nguyen KN, Walsh J, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 2002; 99: 3030.
11. Paik JY, Lee KH, Byun SS, et al. Use of insulin to improve [18F]fluorodeoxyglucose labelling and retention for in vivo positron emission tomography imaging of monocyte trafficking. Nucl Med Commun 2002; 23: 551.
12. Jirak D, Kriz J, Herynek V, et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004; 52: 1228.